Education
About Us
Working with TipRanks
Follow Us
Epigral Ltd (IN:EPIGRAL)
:EPIGRAL
EPIGRAL Stock Chart & Stats
₹1698.50
-₹4.30(-0.24%)
At close: 4:00 PM EST
₹1698.50
-₹4.30(-0.24%)
Day’s Range― - ―
52-Week Range₹1,506.60 - ₹2,233.35
Previous CloseN/A
Volume42.70K
Average Volume (3M)1.86K
Market Cap
₹73.28B
Enterprise Value₹86.84B
Total Cash (Recent Filing)₹952.40M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)16.8
Beta1.41
Next Earnings
Nov 06, 2025EPS Estimate
14.1Last Dividend Ex-Date
Jun 20, 2025Dividend Yield0.35%
Share Statistics
EPS (TTM)18.50
Shares Outstanding43,141,340
10 Day Avg. Volume1,295
30 Day Avg. Volume1,859
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)4.21
Price to Sales (P/S)3.14
P/FCF Ratio32.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹2,027.00Price Target Upside19.34% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Epigral Ltd News
EPIGRAL FAQ
What was Epigral Ltd’s price range in the past 12 months?
Epigral Ltd lowest stock price was ₹1506.60 and its highest was ₹2233.35 in the past 12 months.
What is Epigral Ltd’s market cap?
Epigral Ltd’s market cap is ₹73.28B.
When is Epigral Ltd’s upcoming earnings report date?
Epigral Ltd’s upcoming earnings report date is Nov 06, 2025 which is in 17 days.
How were Epigral Ltd’s earnings last quarter?
Epigral Ltd released its earnings results on Aug 02, 2025. The company reported ₹18.5 earnings per share for the quarter, beating the consensus estimate of ₹17.45 by ₹1.05.
Is Epigral Ltd overvalued?
According to Wall Street analysts Epigral Ltd’s price is currently Undervalued.
Does Epigral Ltd pay dividends?
Epigral Ltd pays a Semiannually dividend of ₹3.5 which represents an annual dividend yield of 0.35%. See more information on Epigral Ltd dividends here
What is Epigral Ltd’s EPS estimate?
Epigral Ltd’s EPS estimate is 14.1.
How many shares outstanding does Epigral Ltd have?
Epigral Ltd has 43,141,340 shares outstanding.
What happened to Epigral Ltd’s price movement after its last earnings report?
Epigral Ltd reported an EPS of ₹18.5 in its last earnings report, beating expectations of ₹17.45. Following the earnings report the stock price went up 0.788%.
Which hedge fund is a major shareholder of Epigral Ltd?
Currently, no hedge funds are holding shares in IN:EPIGRAL
Company Description
Epigral Ltd
Epigral Ltd (EPIGRAL) is a biotechnology company specializing in the development of innovative diagnostic and therapeutic solutions. Operating primarily within the healthcare sector, Epigral focuses on advancing personalized medicine through its cutting-edge technologies, which include molecular diagnostics and targeted therapies. The company's core products aim to improve patient outcomes by providing accurate disease detection and tailored treatment options.
Technical Analysis
Gufic Biosciences Limited
―
Marksans Pharma Limited
―
Shilpa Medicare Limited
―
Strides Pharma Science Ltd
―
Supriya Lifescience Limited
―